Stocks
Ainos, Inc.AIMD
NASDAQTechnologyBiotechnology$0.62
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing novel therapeutics based on its proprietary human interferon alpha technology, with a focus on oral and topical formulations for viral infections and autoimmune diseases. Its lead candidate, AIN457, targets oral mucositis, while the company also explores applications in COVID-19 and other conditions. Investors track AIMD for its pipeline progress and regulatory milestones.
52W Range: $0.56-$3.88
Congressional Interest in Ainos, Inc. (AIMD)
1 member of Congress has disclosed 1 trade in Ainos, Inc. (AIMD), a Technology company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading AIMD?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-09-15 | JAMES B. RENACCI | sell | $15K-$50K |